Stanley A. Schwartz M.D., Ph.D.
Stanley A. Schwartz
M.D., Ph.D.
UB Distinguished Professor, Medicine and Pediatrics; Division Chief; Allergy, Immunology & Rheumatology
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Allergy and Immunology; Antibody-Drug Conjugates; Asthma; Blood-Brain Barrier and Brain Delivery; Blood-Brain Barrier and Drug Delivery; Brain Research; Cancer Treatment and Prevention; Clinical Research; Drug Delivery; Drug Design; Drug Formulation; Drug Targeting; Gene Therapy; HIV Human Immunodeficiency Virus; Immunogenicity; Immunology; Immunology; Immunotherapy; Molecular and Cellular Biology; Molecular Basis of Disease; Monoclonal Antibodies; Nanoparticles; Nanoparticles; Nanotechnology; Neurobiology; Neuroimmunology; Neuroimmunology; Neuropharmacology; Proteomics; Rhinology; Sinus Disorders; Targeted Drug Delivery; Viral Pathogenesis; Virology
Contact Information
Patient Care
Patient Care
This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.
View this physician on UBMDEducation and Training:
- Fellowship, Medical Informatics, Marine Biological Laboratory (2009)
- Fellowship, Clinical Immunology, Memorial Sloan-Kettering Cancer Center (1976)
- Residency, Pediatrics, Albert Einstein College of Medicine (1974)
- Internship, Pediatrics, Albert Einstein College of Medicine (1973)
- MD, Albert Einstein College of Medicine (1972)
- Fellowship, Biology, University of California, San Diego (1969)
- PhD, Cellular Biology, University of California, San Diego (1968)
- MS, Microbiology, Rutgers University (1965)
- BA, Biological Sciences, Rutgers College (1963)
Employment:
- Chief, Division of Allergy, Immunology & Rheumatology, Medicine, University at Buffalo, The State University of New York (1992-present)
- Attending Physician, VA of Western NY (1996-present)
- Professor of Pediatrics, Medicine, University at Buffalo (1994-present)
- Attending Physician, Kaleida Health Systems (1992-present)
- Professor of Medicine, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1992-present)
- Chief, Department of Medicine, Kaleida Health (2007–2016)
- Professor of Microbiology and Immunology, Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (1994–2015)
- Attending Physician, Erie County Medical Center (1996–2010)
- Professor of Epidemiology, The University of Michigan (1984–1992)
- Professor of Pediatrics and Microbiology & Immunology, Pediatrics, The University of Michigan The University of Michigan (1978–1992)
- Assistant Professor, Pediatrics, Cornell University Medical College (1977–1978)
Awards and Honors:
- UB Distinguished Professor (2011)
- Stockton Kimball Award (2003)
- Sustained Academic Achievement Award (2002)
- American Cancer Society Postdoctoral Scholarship (Albert Einstein College)
- Clinical Research Fellowship (Memorial Sloan-Kettering Cancer Center)
- Listed in Best Doctors in the U.S.®
- Listed in Guide to America’s Top Physicians, Consumers’ Research Council
- Meller Award for Outstanding Research (Memorial Sloan-Kettering)
- NIH Research Career Development Award
Research Expertise:
- Allergy and Immunology: Asthma, allergic rhinitis, urticaria, atopic dermatitis, cutaneous vasculitis, primary immunodeficiency, hereditary angioedema
- Immunology: Pathogenesis of HIV Encephalopathy Role of Angiogenesis in Cancer Mechanisms of Airway Remodeling in Asthma
Grants and Sponsored Research:
- January 2022–December 2025
A Multimodal Hierarchical Theranostic Nanoparticle for Castration Resistant Prostate Cance
Department of Veterans Affairs
Role: Principal Investigator - July 2009–June 2011
Integration of Clinical, Genomic and Proteomic Data using Bioinformatic Approach
National Institute of Health
Role: Principal Investigator - July 1999–June 2009
Cocaine in the Immuno- and Neuropathogenesis of HIV Infections
NIH: National Institute on Drug Abuse
Role: Co-Investigator - August 2006
Endowment for the Division of Allergy, Immunology, and Rheumatolgoy
Kaleida Health Foundation
Role: Principal Investigator - January 2001
Development of a Center of Excellence in Tumor Immunology: Regulation of Angiogenesis in Prostate Cancer
Margaret Duffy and Robert Cameron Troup Memorial Fund
Role: Principal Investigator
Patents:
- Method of Using Gold Nonorods-SiRNA Complexes #8, 035, 016 (2011)
Journal Articles:
- Singh H, Shyamveer , Mahajan SD, Aalinkeel R, Kaliyappan K, Schwartz SA, Bhattacharya M, Parvez MK, Al-Dosari MS. (2024) Identification of novel genetic variations in ABCB6 and GRN genes associated with HIV-associated lipodystrophy. Clinica chimica acta; international journal of clinical chemistry (Mar), 556: 117830.
- Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. (2023) Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms (Jun), 11(6). doi:10.3390/microorganisms11061614
- Singh H, Jori C, Shyamveer , Mahajan SD, Aalinkeel R, Kaliyappan K, Schwartz SA, Bhattacharya M, Shaikh R, Salve M, Deshmukh J, Ali N, Parvez MK. (2023) Comparative analysis of MTP -493G/T and ABCG2 34G/A polymorphisms and theirs expression in HIV-associated lipodystrophy patients. Frontiers in cardiovascular medicine (Jan), 10: 1177054. doi:10.3389/fcvm.2023.1177054
- Sharma S, Mahajan SD, Chevli K, Schwartz SA, Aalinkeel R. (2023) Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant Prostate Cancer. Critical reviews in therapeutic drug carrier systems (Jan), 40(4): 69-100. doi:10.1615/CritRevTherDrugCarrierSyst.2022043827
- Sharma S, Cwiklinski K, Mahajan SD, Schwartz SA, Aalinkeel R. (2023) Combination Modality Using Quercetin to Enhance the Efficacy of Docetaxel in Prostate Cancer Cells. Cancers (Jan), 15(3). doi:10.3390/cancers15030902
- Bruggemann L, Falls Z, Mangione W, Schwartz SA, Battaglia S, Aalinkeel R, Mahajan SD, Samudrala R. (2023) Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer. International journal of molecular sciences (Jan), 24(2). doi:10.3390/ijms24020997
- Chean KT, Aalinkeel R, Abbasi S, Sharikova AV, Schwartz SA, Khmaladze A, Mahajan SD. (2022) Raman spectroscopy based molecular signatures of methamphetamine and HIV induced mitochondrial dysfunction. Biochemical and biophysical research communications (Sep), 621: 116-121.
- Sharma S, Cwiklinski K, Sykes DE, Mahajan SD, Chevli K, Schwartz SA, Aalinkeel R. (2022) Use of Glycoproteins-Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer. Cancers (May), 14(11). doi:10.3390/cancers14112704
- Clough E, Inigo J, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. (2021) Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (Oct). doi:10.1007/s11481-021-10015-6
- Mammen MJ, Ali J, Aurora A, Sharma UC, Aalinkeel R, Mahajan SD, Sands M, Schwartz SA. (2021) IL-17 Is a Key Regulator of Mucin-Galectin-3 Interactions in Asthma. International journal of cell biology (Jan), 2021: 9997625. doi:10.1155/2021/9997625
- Harish A, Schwartz SA. (2020) Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions. Clinical reviews in allergy & immunology (Oct), 59(2): 273.
- Harish A, Schwartz SA. (2020) Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions. Clinical reviews in allergy & immunology (Oct), 59(2): 231-247.
- Bulmahn JC, Kutscher HL, Cwiklinski K, Schwartz SA, Prasad PN, Aalinkeel R. (2020) A Multimodal Theranostic Nanoformulation That Dramatically Enhances Docetaxel Efficacy Against Castration Resistant Prostate Cancer. Journal of pharmaceutical sciences (Sep), 109(9): 2874-2883.
- Sharma A, Yadav A, Gupta N, Sharma S, Kakkar R, Cwiklinski K, Quaye E, Mahajan SD, Schwartz SA, Kumar Sharma R. (2019) Multifunctional mesoporous curcumin encapsulated iron-phenanthroline nanocluster: A new Anti-HIV agent. Colloids and surfaces. B, Biointerfaces (Aug), 180: 289-297.
- Dai L, Liu A, Zhang H, Wu H, Zhang T, Su B, Shao Y, Li J, Ye J, Scott SR, Mahajan SD, Schwartz SA, Yu H, Sun L. (2019) Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study. Current HIV research (Jan), 17(5): 324-334.
- Patel S, Parikh NU, Aalinkeel R, Reynolds JL, Dmello R, Schwartz SA, Mahajan SD. (2018) United States National Trends in Mortality, Length of Stay (LOS) and Associated Costs of Cognitive Impairment in HIV Population from 2005 to 2014. AIDS Behav (Oct), 22(10): 3198-3208.
- Sharikova AV, Quaye E, Park JY, Maloney MC, Desta H, Thiyagarajan R, Seldeen KL, Parikh NU, Sandhu P, Khmaladze A, Troen BR, Schwartz SA, Mahajan SD. (2018) Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (Sep), 13(3): 396-411.
- Sharikova AV, Quaye E*, Aalinkeel R, Park JY, Maloney MC, Desta H, Thiyagarajan R, Seldeen K, Khmaladze A, Troen B, Schwartz SA and Mahajan SD. (2018) Methamphetamine-induced mitochondrial toxicity is a major determinant of microglial apoptosis. J Neuroimmune Pharmacol (Sep), 13(3): 396-411.
- Mammen MJ, Sands MF, Abou-Jaoude E, Aalinkeel R, Reynolds JL, Parikh NU, Sharma U, Schwartz SA, Mahajan SD. (2018) Role of Galectin-3 in the pathophysiology underlying allergic lung inflammation in a tissue inhibitor of metalloproteinases 1 knockout model of murine asthma. Immunology (Mar), 153(3): 387-396.
- Schwartz SA. (2018) Mitochondrial dysfunction in an aging HIV patient cohort with HIV associated neurological disorders (HAND). Journal of Neurovirology (Jan), 24.
- Sharma RK, Cwiklinski K, Aalinkeel R, Reynolds JL, Sykes DE, Quaye E, Oh J, Mahajan SD, Schwartz SA. (2017) Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic. Immunol Invest (Nov), 46(8): 833-846.
- Mahajan SD, Aalinkeel R, Parikh NU, Jacob A, Cwiklinski K, Sandhu P, Le K, Loftus AW, Schwartz SA, Quigg RJ, Alexander JJ. (2017) Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunol Invest (Nov), 46(8): 816-832.
- Aalinkeel R, Kutscher HL, Singh A, Cwiklinski K, Khechen N, Schwartz SA, Prasad PN, Mahajan SD. (2017) Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer‘s disease?. J Drug Targeting (Jul), 26(2): 182-193.
- Aalinkeel R, Mangum CS, Abou-Jaoude E, Reynolds JL, Liu M, Sundquist K, Parikh NU, Chaves LD, Mammen MJ, Schwartz SA, Mahajan SD. (2017) Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 "Nanoplex" a Possible Neurotherapeutic?. J Neuroimmune Pharmacol (Mar), 12(1): 133-151.
- Aalinkeel R, Nair B, Chen CK, Mahajan SD, Reynolds JL, Zhang H, Sun H, Sykes DE, Chadha KC, Turowski SG, Bothwell KD, Seshadri M, Cheng C, Schwartz SA. (2016) Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis. Immunology (Aug), 148(4): 387-406.
- Shen X, Nair B, Mahajan SD, Jiang X, Li J, Shen S, Tu C, Hsiao CB, Schwartz SA, Qu J. (2015) New Insights into the Disease Progression Control Mechanisms by Comparing Long-Term-Nonprogressors versus Normal-Progressors among HIV-1-Positive Patients Using an Ion Current-Based MS1 Proteomic Profiling. Journal of proteome research (Dec), 14(12): 5225-39.
- Chadha KC, Nair B, Godoy A, Rajnarayanan R, Nabi E, Zhou R, Patel NR, Aalinkeel R, Schwartz SA, Smith GJ. (2015) Anti-angiogenic activity of PSA-derived peptides. Prostate (Sep), 75(12): 1285-1299.
- Mahajan SD, Parikh NU, Woodruff TM, Jarvis JN, Lopez M, Hennon TR, Cunningham P, Quigg RJ, Schwartz SA, Alexander JJ. (2015) C5a Alters Blood-brain Barrier Integrity in a Human in Vitro Model of Systemic Lupus Erythematosus. Immunology (Sep), 146(1): 130-143.
- Parikh N, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Mammen MJ, Schwartz SA, Mahajan SD. (2015) Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain barrier integrity. Brain Res (Jul).
- Ignatowski TA, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Gleason CP, Law WC, Mammen MJ, Prasad PN, Schwartz SA, Mahajan SD. (2015) Nanotherapeutic Approach for Opiate Addiction Using DARPP-32 Gene Silencing in an Animal Model of Opiate Addiction. J Neuroimmune Pharmacol (Mar), 10(1): 136-152.
- Mahajan SD, Gaekwad A, Pawar J, Tripathy S, Ghate M, Bhattacharya J, Singh HO, Schwartz SA, Paranjape R, Gangakhedkar R. (2015) Cardiac morbidity in an HIV-1 lipodystrophy patient cohort expressing the TNF-a-238 G/A single nucleotide gene polymorphism. Curr HIV Res (Jan), 13(2): 98-108.
- Mahajan SD, Gaekwad A, Pawar J, Tripathy S, Ghate M, Bhattacharya J, Singh HO, Schwartz SA, Paranjape R, Gangakhedkar R. (2015) Cardiac morbidity in an HIV-1 lipodystrophy patient cohort expressing the TNF-α-238 G/A single nucleotide gene polymorphism. Curr HIV Res (Jan), 13(2): 98-108.
- Dai L, Li N, Wei F, Li J, Liu Y, Xia W, Zhang T, Guo C, Wang W, Schwartz SA, Mahajan SD, Hsiao CB, Wu H. (2014) Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008-2011. Viral Immunol (Oct), 27(8): 392-397.
- Chen CK, Law WC, Aalinkeel R, Yu Y, Nair B, Wu J, Mahajan S, Reynolds JL, Li Y, Lai CK, Tzanakakis ES, Schwartz SA, Prasad PN, Cheng C. (2014) Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. Nanoscale (Jan), 6(3): 1567-1572.
- Chadha KC, Miller A, Nair BB, Schwartz SA, Trump DL, Underwood W. (2014) New serum biomarkers for prostate cancer diagnosis. Clin Cancer Investig J (Jan), 3(1): 72-79.
- Liu L, Hu R, Roy I, Lin G, Ye L, Reynolds JL, Liu J, Liu J, Schwartz SA, Zhang X, Yong KT. (2013) Synthesis of luminescent near-infrared AgInS2 nanocrystals as optical probes for in vivo applications. Theranostics (Feb), 3(2): 109-115.
- Brown P, Nair B, Mahajan SD, Sykes DE, Rich G, Reynolds JL, Aalinkeel R, Wheeler J, Schwartz SA. (2012) Single nucleotide polymorphisms (SNPs) in key cytokines may modulate food allergy phenotypes. Eur Food Res Technol (Nov), 235(5): 971-980.
- Chen CK, Law WC, Aalinkeel R, Nair B, Kopwitthaya A, Mahajan SD, Reynolds JL, Zou J, Schwartz SA, Prasad PN, Cheng C. (2012) Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer. Adv Healthc Mater (Nov), 1(6): 751-761.
- Mahajan SD, Aalinkeel R, Law WC, Reynolds JL, Nair BB, Sykes DE, Yong KT, Roy I, Prasad PN, Schwartz SA. (2012) Anti-HIV-1 nanotherapeutics: promises and challenges for the future. Int J Nanomedicine (Oct), 7: 5301-5314.
- Law WC, Mahajan SD, Kopwitthaya A, Reynolds JL, Liu M, Liu X, Chen G, Erogbogbo F, Vathy L, Aalinkeel R, Schwartz SA, Yong KT, Prasad PN. (2012) Gene Silencing of Human Neuronal Cells for Drug Addiction Therapy using Anisotropic Nanocrystals. Theranostics (Jul), 2(7): 695-704.
- Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Yong KT, Hui R, Prasad PN, Schwartz SA. (2012) Nanoparticle Based Galectin-1 Gene Silencing, Implications in Methamphetamine Regulation of HIV-1 Infection in Monocyte Derived Macrophages. J Neuroimmune Pharmacol (Jun).
- Aalinkeel R, Nair B, Reynolds JL, Sykes DE, Law WC, Mahajan SD, Prasad PN, Schwartz SA. (2012) Quantum rods as nanocarriers of gene therapy. Drug Deliv (May), 19(4): 220-231.
- Reynolds JL, Law WC, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Mammen MJ, Yong KT, Hui R, Prasad PN, Schwartz SA. (2012) Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages. J Immunol (Apr), 188(8): 3757-3765.
- Mahajan SD, Law WC, Aalinkeel R, Reynolds J, Nair BB, Yong KT, Roy I, Prasad PN, Schwartz SA. (2012) Nanoparticle-mediated targeted delivery of antiretrovirals to the brain. Methods Enzymol (Jan), 509: 41-60.
- Schwartz SA. (2012) Anti-HIV nanotherapeutics: promises and challenges for the future. International Journal of Nanomedicine (Jan), 7: 5301-5314.
- Chadha KC, Nair BB, Chakravarthi S, Zhou R, Godoy A, Mohler JL, Aalinkeel R, Schwartz SA, Smith GJ. (2011) Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities. Prostate (Nov), 71(15): 1680-1690.
- Nair B, Wheeler JC, Sykes DE, Brown P, Reynolds JL, Aalinkeel R, Mahajan SD, Schwartz SA. (2011) Proteomic Approach to Evaluate Mechanisms That Contribute to Food Allergenicity: Comparative 2D-DIGE Analysis of Radioallergosorbent Test Positive and Negative Patients. Int J Proteomics (Sep), 2011: 673618-673618.
- Mahajan SD, Aalinkeel R, Reynolds JL, Nair B, Sykes DE, Bonoiu A, Roy I, Yong KT, Law WC, Bergey EJ, Prasad PN, Schwartz SA. (2011) Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex. Immunol Invest (Aug), 41(4): 337-355.
- Mahajan SD, Aalinkeel R, Reynolds JL, Nair B, Sykes DE, Law WC, Ding H, Bergey EJ, Prasad PN, Schwartz SA. (2011) Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNA. Patholog Res Int (May), 2011: 719139-719139.
- Aalinkeel R, Nair BB, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, Schwartz SA. (2011) Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP. Immunol Invest (Mar), 40(5): 447-464.
- Reynolds JL, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Schwartz SA. (2011) Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages. Immunol Invest (Mar), 40(5): 481-497.
- Mahajan SD, Roy I, Xu G, Yong KT, Ding H, Aalinkeel R, Reynolds J, Sykes D, Nair BB, Lin EY, Prasad PN, Schwartz SA. (2010) Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles. Curr HIV Res (Jul), 8(5): 396-404.
- Aalinkeel R, Hu Z, Nair BB, Sykes DE, Reynolds JL, Mahajan SD, Schwartz SA. (2010) Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid-'Ashwagandha' in Prostate Cancer Cells. Evid Based Complement Alternat Med (Jun), 7(2): 177-187.
- Mahajan SD, Agosto-Mojica A, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Martinez J, Adams J, Singh N, Bernstein Z, Hsiao CB, Schwartz SA, Hsiao C. (2010) Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease. Biochem Biophys Res Commun (May), 396(2): 348-352.
- Reynolds JL, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Agosto-Mujica A, Hsiao CB, Schwartz SA, Hsiao C. (2009) Modulation of the proteome of peripheral blood mononuclear cells from HIV-1-infected patients by drugs of abuse. J Clin Immunol (Sep), 29(5): 646-656.
- Bonoiu A, Mahajan SD, Ye L, Kumar R, Ding H, Yong KT, Roy I, Aalinkeel R, Nair B, Reynolds JL, Sykes DE, Imperiale MA, Bergey EJ, Schwartz SA, Prasad PN. (2009) MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res (Jul), 1282: 142-155.
- Bonoiu AC, Mahajan SD, Ding H, Roy I, Yong KT, Kumar R, Hu R, Bergey EJ, Schwartz SA, Prasad PN. (2009) Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc Natl Acad Sci U S A (Apr), 106(14): 5546-5550.
- Sands MF, Ohtake PJ, Mahajan SD, Takyar SS, Aalinkeel R, Fang YV, Blume JW, Mullan BA, Sykes DE, Lachina S, Knight PR, Schwartz SA. (2009) Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol (Feb), 130(2): 186-198.
- Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Sykes DE, Hu Z, Bonoiu A, Ding H, Prasad PN, Schwartz SA. (2009) Therapeutic targeting of "DARPP-32": a key signaling molecule in the dopiminergic pathway for the treatment of opiate addiction. Int Rev Neurobiol (Jan), 88: 199-222.
- Reynolds JL, Mahajan SD, Aalinkeel R, Nair B, Sykes DE, Schwartz SA. (2009) Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells. Immunol Invest (Jan), 38(6): 526-550.
- Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, Schwartz SA. (2008) The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate (Dec), 68(16): 1773-1789.
- Schwartz SA. (2008) Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells. Prostate (Oct), 68(14): 1531-1545.
- Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Fernandez SF, Chawda R, Shanahan TC, Schwartz SA. (2008) Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability. J Clin Immunol (Sep), 28(5): 528-541.
- Xu G, Yong KT, Roy I, Mahajan SD, Ding H, Schwartz SA, Prasad PN. (2008) Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier. Bioconjug Chem (Jun), 19(6): 1179-1185.
- Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Adal A, Qi M, Toh J, Xu G, Prasad PN, Schwartz SA. (2008) Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res (Apr), 1203: 133-148.
- Bernstein ZP, Dougherty T, Gollnick S, Schwartz SA, Mahajan SD, Kepner J, Sumlin A, Stewart C, Wallace P, Adal A, Walder H, Poiesz B. (2008) Photopheresis in HIV-1 infected patients utilizing benzoporphyrin derivative (BPD) verteporfin and light. Curr HIV Res (Mar), 6(2): 152-163.
- Bindukumar B, Mahajan SD, Reynolds JL, Hu Z, Sykes DE, Aalinkeel R, Schwartz SA. (2008) Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res (Jan), 1191: 1-11.
- Sands MF, Blume JW, Schwartz SA. (2007) Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol (Oct), 120(4): 979-981.
- Reynolds JL, Mahajan SD, Sykes DE, Schwartz SA, Nair MP. (2007) Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim Biophys Acta (Apr), 1774(4): 433-442.
- Reynolds JL, Mahajan SD, Bindukumar B, Sykes D, Schwartz SA, Nair MP. (2006) Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res (Dec), 1123(1): 226-236.
- Ludwig LB, Ambrus JL, Krawczyk KA, Sharma S, Brooks S, Hsiao CB, Schwartz SA. (2006) Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology (Nov), 3: 80-80.
- Nair MP, Mahajan S, Reynolds JL, Aalinkeel R, Nair H, Schwartz SA, Kandaswami C. (2006) The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol (Mar), 13(3): 319-328.
- Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA, Nair MP. (2006) Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther (Jan), 10(4): 257-269.
- Nair MP, Reynolds JL, Mahajan SD, Schwartz SA, Aalinkeel R, Bindukumar B, Sykes D. (2005) RNAi-directed inhibition of DC-SIGN by dendritic cells: prospects for HIV-1 therapy. AAPS J (Oct), 7(3): 572-578.
- Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Fernandez SF, Schwartz SA, Nair MP. (2005) Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res (Jul), 3(3): 277-288.
- Mahajan SD, Schwartz SA, Aalinkeel R, Chawda RP, Sykes DE, Nair MP. (2005) Morphine modulates chemokine gene regulation in normal human astrocytes. Clin Immunol (Jun), 115(3): 323-332.
- Nair MP, Mahajan SD, Schwartz SA, Reynolds J, Whitney R, Bernstein Z, Chawda RP, Sykes D, Hewitt R, Hsiao CB, Hsiao C. (2005) Cocaine modulates dendritic cell-specific C type intercellular adhesion molecule-3-grabbing nonintegrin expression by dendritic cells in HIV-1 patients. J Immunol (Jun), 174(11): 6617-6626.
- Bindukumar B, Schwartz SA, Nair MP, Aalinkeel R, Kawinski E, Chadha KC. (2005) Prostate-Specific Antigen Modulates the Expression of Genes Involved in Prostate Tumor Growth. Neoplasia (May), 7(5): 544-544.
- Bindukumar B, Schwartz SA, Nair MP, Aalinkeel R, Kawinski E, Chadha KC. (2005) Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth. Neoplasia (New York, N.Y.) (Mar), 7(3): 241-52. doi:10.1593/neo.04529
- Nair MP, Schwartz SA, Mahajan SD, Tsiao C, Chawda RP, Whitney R, Don Sykes BB, Hewitt R. (2004) Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. J Neuroimmunol (Dec), 157(1-2): 56-60.
- Bindukumar B, Kawinski E, Cherrin C, Gambino LM, Nair MP, Schwartz SA, Chadha KC. (2004) Two step procedure for purification of enzymatically active prostate-specific antigen from seminal plasma. J Chromatogr B Analyt Technol Biomed Life Sci (Dec), 813(1-2): 113-120.
- Aalinkeel R, Nair MP, Sufrin G, Mahajan SD, Chadha KC, Chawda RP, Schwartz SA. (2004) Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res (Aug), 64(15): 5311-5321.
- Nair MP, Mahajan S, Hewitt R, Whitney ZR, Schwartz SA. (2004) Association of drug abuse with inhibition of HIV-1 immune responses: studies with long-term of HIV-1 non-progressors. J Neuroimmunol (Feb), 147(1-2): 21-25.
- Nair HK, Rao KV, Aalinkeel R, Mahajan S, Chawda R, Schwartz SA. (2004) Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol (Jan), 11(1): 63-69.
- Chadha KC, Schwartz SA, Nair MP, Demeter LR, Hewitt RG. (2003) Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy. Immunol Invest (Nov), 32(4): 299-312.
- Mahajan SD, Schwartz SA, Nair MP. (2003) Immunological assays for chemokine detection in in-vitro culture of CNS cells. Biol Proced Online (Jan), 5: 90-102.
- Mahajan SD, Aalinkeel R, Schwartz SA, Chawda RP, Nair MP. (2003) Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects. Biol Proced Online (Jan), 5: 182-188.
- Nair MP, Kandaswami C, Mahajan S, Chadha KC, Chawda R, Nair H, Kumar N, Nair RE, Schwartz SA. (2002) The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta (Dec), 1593(1): 29-36.
- Mahajan SD, Schwartz SA, Shanahan TC, Chawda RP, Nair MP. (2002) Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol (Oct), 169(7): 3589-3599.
- Nesbit CE, Schwartz SA. (2002) In vitro and animal models of human immunodeficiency virus infection of the central nervous system. Clin Diagn Lab Immunol (May), 9(3): 515-524.
- Nair N, Mahajan S, Chawda R, Kandaswami C, Shanahan TC, Schwartz SA. (2002) Grape seed extract activates Th1 cells in vitro. Clin Diagn Lab Immunol (Mar), 9(2): 470-476.
- Nair MP, Kandaswami C, Mahajan S, Nair HN, Chawda R, Shanahan T, Schwartz SA. (2002) Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells. Biol Res (Jan), 35(3-4): 421-431.
- Nair MP, Mahajan S, Chadha KC, Nair NM, Hewitt RG, Pillai SK, Chadha P, Sukumaran PC, Schwartz SA. (2001) Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients. Adv Exp Med Biol (Jan), 493: 235-240.
- Schwartz SA. (2000) Intravenous immunoglobulin treatment of immunodeficiency disorders. Pediatr Clin North Am (Dec), 47(6): 1355-1369.
- Mahajan S, Hou J, Sweet AM, Schwartz SA. (2000) The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells. Cell Mol Biol (Noisy-le-grand) (Nov), 46(7): 1227-1238.
- Nair MP, Schwartz SA. (2000) Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2. Clin Diagn Lab Immunol (Jan), 7(1): 101-105.
- Madhavan Nair, Chadha KC, Ross Hewitt, Mahajan S, Sweet A, Stanley Schwartz. (2000) Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol (Jan), 7(1): 96-100.
- Nair MP, Chadha KC, Hewitt RG, Mahajan S, Sweet A, Schwartz SA. (2000) Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clinical and diagnostic laboratory immunology (Jan), 7(1): 96-100. doi:10.1128/cdli.7.1.96-100.2000
- Nair MPN, Schwartz SA. (2000) Reversal of human immunodeficiency virus type I protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2. Clin Diagn Lab Immunol (Jan), 7: 101-105.
- Schwartz SA, Nair MP. (1999) Current concepts in human immunodeficiency virus infection and AIDS. Clin Diagn Lab Immunol (May), 6(3): 295-305.
- Madhavan Nair, Mahajan, Supriya, Chadha, Kailash C., Ross Hewitt, Stanley Schwartz. (1999) Immunopathogenesis of HIV infection. Role of recreational drugs. Recent Research Developments in Immunology (Jan), 1: 597-606.
- Nair MP, Schwartz SA. (1997) Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I. Cell Mol Biol (Noisy-le-grand) (Nov), 43(7): 969-979.
- Schwartz SA, Nair MP. (1997) Molecular mechanisms in the pathogenesis of AIDS encephalopathy. Cell Mol Biol (Noisy-le-grand) (Nov), 43(7): 925-933.
- el-Solh A, Kumar NM, Nair MP, Schwartz SA, Lwebuga-Mukasa JS. (1997) An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549. Immunol Invest (Apr), 26(3): 351-370.
- Nair MP, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC. (1997) Immunoregulatory effects of morphine on human lymphocytes. Clin Diagn Lab Immunol (Mar), 4(2): 127-132.
- Nair, M.P.N., Kumar, N., Kronfol, Z.A., Greden, J.F., Lwebuga-Mukasa, J.S, and Schwartz, S.A. (1996) Alcohol inhibits lipopolysaccaride-induced tumor necrosis factor alpha gene expression by peripheral blood mononuclear cells as measured by reverse transcriptase PCR in situ hybridization. Clinical and Diagnostic Laboratory Immunology (Jul), 3(4): 392-398.
- Nair MP, Kumar NM, Kronfol ZA, Greden JF, Lwebuga-Mukasa JS, Schwartz SA. (1996) Alcohol inhibits lipopolysaccharide-induced tumor necrosis factor alpha gene expression by peripheral blood mononuclear cells as measured by reverse transcriptase PCR in situ hybridization. Clin Diagn Lab Immunol (Jul), 3(4): 392-398.
- Nair MP, Schwartz SA. (1996) Immunopathogenesis of HIV infection: role of alcohol and HIV peptides. Adv Exp Med Biol (Jan), 402: 165-170.
- Nair MP, Schwartz SA. (1995) Substance P induces tumor necrosis factor in an ex vivo model system. Cell Immunol (Dec), 166(2): 286-290.
- Ramesh S, Schwartz SA. (1995) Therapeutic uses of intravenous immunoglobulin (IVIG) in children. Pediatr Rev (Nov), 16(11): 403-410.
- Ludwig LB, Hughes BJ, Schwartz SA. (1995) Biotinylated probes in the electrophoretic mobility shift assay to examine specific dsDNA, ssDNA or RNA-protein interactions. Nucleic Acids Res (Sep), 23(18): 3792-3793.
- Nair MP, Saravolatz LD, Schwartz SA. (1995) Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lymphocytes from AIDS patients. Immunol Invest (Aug), 24(5): 689-699.
- Schwartz SA. (1995) Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lympocytes from AIDS patients. Immunological Investigations (Aug), 24(5): 689-699.
- Nair MP, Chadha KC, Stadler I, Sweet A, Schwartz SA. (1995) Differential effects of human immunodeficiency virus type 1 envelope protein gp120 on interferon production by mononuclear cells from adults and neonates. Clin Diagn Lab Immunol (Jul), 2(4): 434-438.
- Schwartz DG, Schwartz SA. (1995) MEDLINE training for medical students integrated into the clinical curriculum. Med Educ (Mar), 29(2): 133-138.
- Nair MP, Schwartz SA. (1995) Synergistic effect of cortisol and HIV-1 envelope peptide on the NK activities of normal lymphocytes. Brain Behav Immun (Mar), 9(1): 20-30.
- Nair MP, Schwartz SA. (1995) Substance P induces tumor necrosis factor in an ex vivo model system. Cell Immunol (Jan), 166: 286-290.
- Nair MP, Kronfol ZA, Greden JF, Chadha KC, Dumaswala UJ, Sweet AM, Schwartz SA. (1994) Selective inhibition by alcohol and cortisol of natural killer cell activity of lymphocytes from cord blood. Prog Neuropsychopharmacol Biol Psychiatry (Dec), 18(8): 1293-1305.
- Abdeljaber MH, Nair MP, Schork MA, Schwartz SA. (1994) Depressed natural killer cell activity in schizophrenic patients. Immunol Invest (Aug), 23(4-5): 259-268.
- Nair MP, Schwartz SA, Kronfol ZA, Hill EM, Sweet AM, Greden JF. (1994) Suppression of tumor necrosis factor production by alcohol in lipopolysaccharide-stimulated culture. Alcohol Clin Exp Res (Jun), 18(3): 602-607.
- Taki HN, Schwartz SA. (1994) Levamisole as an immunopotentiator for T cell deficiency. Immunopharmacol Immunotoxicol (May), 16(2): 129-137.
- Nair MP, Kumar NM, Kronfol ZA, Saravolatz LA, Pottathil R, Greden JF, Schwartz SA. (1994) Selective effect of alcohol on cellular immune responses of lymphocytes from AIDS patients. Alcohol (Mar), 11(2): 85-90.
- Ludwig LB, Schwartz SA, Insel RA. (1994) Human monoclonal lambda light chain protein exhibits specific binding to the variable region of monoclonal anti-IgE antibody. Cell Immunol (Jan), 153(1): 117-130.
- Taki HN, Schwartz SA. (1993) Two siblings with recurrent infections. Ann Allergy (Nov), 71(5): 435-438.
- Nair MP, Sweet AM, Schwartz SA. (1993) Immunoregulation of tumor necrosis factor production by HIV-1 gp-120 in neonates and adults. Ann N Y Acad Sci (Oct), 693: 309-311.
- Barks JD, Nair MP, Schwartz SA, Silverstein FS. (1993) Potentiation of N-methyl-D-aspartate-mediated brain injury by a human immunodeficiency virus-1-derived peptide in perinatal rodents. Pediatr Res (Aug), 34(2): 192-198.
- Nair MP, Schwartz SA, Wu K, Kronfol Z. (1993) Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav Immun (Mar), 7(1): 70-78.
- Schwartz DG, Schwartz SA. (1992) MEDLINE training for medical students in the clinical curriculum. Acad Med (Jul), 67(7): 484-484.
- Schwartz SA. (1992) Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes. Clin Rev Allergy (Jan), 10(1-2): 1-12.
- Halpern MT, Schwartz SA. (1991) Modulation of a human immunosuppressive lymphokine by monosaccharides. Cell Immunol (Aug), 136(1): 29-40.
- Adib SM, Joseph JG, Ostrow DG, Tal M, Schwartz SA. (1991) Relapse in sexual behavior among homosexual men: a 2-year follow-up from the Chicago MACS/CCS. AIDS (Jun), 5(6): 757-760.
- Nair MP, Schwartz SA. (1990) Immunoregulation of natural and lymphokine-activated killer cells by selenium. Immunopharmacology (May), 19(3): 177-183.
- Schwartz SA. (1990) Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. J Clin Immunol (Mar), 10(2): 81-89.
- Nair MP, Kronfol ZA, Schwartz SA. (1990) Effects of alcohol and nicotine on cytotoxic functions of human lymphocytes. Clin Immunol Immunopathol (Mar), 54(3): 395-409.
- Bharucha-Reid R, Schork MA, Schwartz SA. (1990) Data linkage and subject anonymity for HIV testing. AIDS Public Policy J (Jan), 5(4): 189-190.
- Nair MP, Schwartz SA, Kronfol ZA, Heimer EP, Pottathil R, Greden JF. (1990) Immunoregulatory effects of alcohol on lymphocyte responses to human immunodeficiency virus proteins. Prog Clin Biol Res (Jan), 325: 221-230.
- Kronfol Z, Nair M, Goodson J, Goel K, Haskett R, Schwartz S. (1989) Natural killer cell activity in depressive illness: preliminary report. Biological psychiatry (Nov), 26(7): 753-6.
- Schwartz SA, Gordon KE, Johnston MV, Goldstein GW. (1989) Use of intravenous immune globulin in the treatment of seizure disorders. J Allergy Clin Immunol (Oct), 84(4 Pt): 603-606.
- Pahwa R, Chatila T, Pahwa S, Paradise C, Day NK, Geha R, Schwartz SA, Slade H, Oyaizu N, Good RA. (1989) Recombinant interleukin 2 therapy in severe combined immunodeficiency disease. Proc Natl Acad Sci U S A (Jul), 86(13): 5069-5073.
- Monto AS, Schwartz SA, Albrecht JK. (1989) Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families. Antimicrob Agents Chemother (Mar), 33(3): 387-390.
- Slade HB, Schwartz SA. (1989) Antigen-driven immunoglobulin production by human colostral lymphocytes. Pediatr Res (Mar), 25(3): 295-299.
- Slade HB, Greenwood JH, Beekman RH, McCoy JP, Hudson JL, Pahwa S, Schwartz SA. (1989) Flow cytometric analysis of lymphocyte subpopulations in infants with congenital heart disease. J Clin Lab Anal (Jan), 3(1): 14-20.
- Nair MP, Schwartz SA. (1988) Immunoregulation of human natural killer cells (NK) by corticosteroids: inhibitory effect of culture supernatants. J Allergy Clin Immunol (Dec), 82(6): 1089-1097.
- Nair MP, Schwartz SA. (1988) Immunoregulation of lymphokine-activated killer cells. Clin Immunol Immunopathol (Oct), 49(1): 28-40.
- Nair MP, Pottathil R, Heimer EP, Schwartz SA. (1988) Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci U S A (Sep), 85(17): 6498-6502.
- Slade HB, Greenwood JH, Hudson JL, Beekman RH, Riedy MC, Schwartz SA. (1988) Lymphocyte phenotyping of infants with congenital heart disease: comparison of cell preparation techniques. Diagn Clin Immunol (Jan), 5(5): 249-255.
- Monto AS, Albrecht JK, Schwartz SA. (1988) Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon. Antimicrob Agents Chemother (Jan), 32(1): 47-50.
- Nair MP, Gray RH, Boxer LA, Schwartz SA. (1987) Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome. Am J Hematol (Sep), 26(1): 55-66.
- Slade HB, Schwartz SA. (1987) Mucosal immunity: the immunology of breast milk. J Allergy Clin Immunol (Sep), 80(3 Pt): 348-358.
- Bishop GA, McCurry L, Schwartz SA, Glorioso JC. (1987) Activation of human natural killer cells by herpes simplex virus type 1-infected cells. Intervirology (Jan), 28(2): 78-88.
- Slade HB, Lopatin DE, Schwartz SA. (1986) Measurement of immunoglobulin concentration in cell culture supernates by computer-assisted ELISA. J Immunol Methods (Nov), 94(1-2): 169-179.
- Nair MP, Lewis EW, Schwartz SA. (1986) Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities. J Clin Immunol (Sep), 6(5): 363-372.
- Monto AS, Shope TC, Schwartz SA, Albrecht JK. (1986) Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection. J Infect Dis (Jul), 154(1): 128-133.
- Nair MP, Cilik JM, Schwartz SA. (1986) Histamine-induced suppressor factor inhibition of NK cells: reversal with interferon and interleukin 2. J Immunol (Apr), 136(7): 2456-2462.
- Hanash SM, Baier LJ, McCurry L, Schwartz SA. (1986) Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis. Proc Natl Acad Sci U S A (Feb), 83(3): 807-811.
- Nair MP, Laing TJ, Schwartz SA. (1986) Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers. Clin Immunol Immunopathol (Jan), 38(1): 68-78.
- Bishop GA, Kümel G, Schwartz SA, Glorioso JC. (1986) Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J Virol (Jan), 57(1): 294-300.
- Shou L, Liu JY, Schwartz SA, Peng R, Chen LK, Good RA. (1985) Separation and further characterization of early and late rosette-forming cells. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi (Nov), 18(4): 211-223.
- Slade HB, Schwartz SA. (1985) Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4. N Engl J Med (Oct), 313(14): 891-891.
- Slade HB, Schwartz SA. (1985) Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjögren's syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4. N Engl J Med (Oct), 313(14): 891-891.
- Nair MP, Schwartz SA, Menon M. (1985) Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates. Cell Immunol (Aug), 94(1): 159-171.
- Nair MP, Schwartz SA, Slade HB, Johnson MZ, Quebbeman JF, Beer AE. (1985) Comparison of the cellular cytotoxic activities of colostral lymphocytes and maternal peripheral blood lymphocytes. J Reprod Immunol (May), 7(3): 199-213.
- Kurup VP, Nair MP, Schwartz SA, Fink JN. (1985) Serum antibodies and their role in antibody-dependent cell-mediated cytotoxicity in aspergillosis. Immunobiology (May), 169(4): 362-371.
- Nair MP, Schwartz SA. (1984) Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's syndrome. Clin Immunol Immunopathol (Dec), 33(3): 412-424.
- Bishop GA, Marlin SD, Schwartz SA, Glorioso JC. (1984) Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. J Immunol (Oct), 133(4): 2206-2214.
- Slepian IK, Schwartz SA, Weiss JJ, Roth SL, Mathews KP. (1984) Immunodeficiency with hyper IgM after systemic lupus erythematosus. J Allergy Clin Immunol (Jun), 73(6): 846-857.
- Nair MP, Schwartz SA. (1984) Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes. J Immunol (Jun), 132(6): 2876-2882.
- Nair MP, Schwartz SA. (1983) Effect of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro. Cell Immunol (Oct), 81(1): 45-60.
- Bishop GA, Glorioso JC, Schwartz SA. (1983) Role of interferon in human natural killer activity against target cells infected with HSV-1. J Immunol (Oct), 131(4): 1849-1853.
- Bishop GA, Glorioso JC, Schwartz SA. (1983) Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med (May), 157(5): 1544-1561.
- Nair MP, Schwartz SA. (1982) Suppression of human natural and antibody-dependent cytotoxicity by soluble factors from unstimulated normal lymphocytes. J Immunol (Dec), 129(6): 2511-2518.
- Bishop GA, Schwartz SA. (1982) Enhancement of human natural killer cells by interferon requires RNA and protein synthesis. Clin Immunol Immunopathol (Dec), 25(3): 374-385.
- Moidel RA, Schwartz SA, Schnitzer TJ. (1982) Regulation of concanavalin A-activated suppressor cell activity by interferon. J Rheumatol (Sep), 9(5): 665-670.
- King AJ, Schwartz SA, Lopatin D, Voorhees JJ, Diaz LA. (1982) Suppressor cell function is preserved in pemphigus and pemphigoid. J Invest Dermatol (Sep), 79(3): 183-185.
- Nair MP, Schwartz SA. (1982) Immunomodulatory effects of amphotericin-B on cellular cytotoxicity of normal human lymphocytes. Cell Immunol (Jul), 70(2): 287-300.
- King AJ, Schwartz SA, Lopatin DE, Voorhees JJ, Diaz LA. (1981) Autoimmunity. Int J Dermatol (Dec), 20(10): 642-646.
- Nair MP, Schwartz SA. (1981) Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes. J Immunol (Jun), 126(6): 2221-2229.
- Nair MP, Schwartz SA, Fernandes G, Pahwa R, Ikehara S, Good RA. (1981) Suppression of natural killer (NK) cell activity of spleen cells by thymocytes. Cell Immunol (Feb), 58(1): 9-18.
- Shou L, Schwartz SA, Good RA, Peng R, Chen CL. (1980) A human soluble suppressor factor affecting lymphocyte responses in vitro. Proc Natl Acad Sci U S A (Oct), 77(10): 6096-6100.
- Rao KM, Schwartz SA. (1980) Zinc modulates mitogenic responses of human lymphocytes by affecting structures influenced by cytochalasin B. Clin Immunol Immunopathol (Aug), 16(4): 463-473.
- Schwartz SA. (1980) Heavy chain-specific suppression of immunoglobulin synthesis and secretion by lymphocytes from patients with selective IgA deficiency. J Immunol (Apr), 124(4): 2034-2041.
- Rao KM, Schwartz SA, Good RA. (1979) Modulation of the mitogenic response of lymphocytes from young and aged individuals by prostaglandins and indomethacin. Cell Immunol (Nov), 48(1): 155-165.
- Gupta S, Schwartz SA, Good RA. (1979) Subpopulations of human T lymphocytes. VII. Cellular basis of concanavalin A-induced T cell-mediated suppression of immunoglobulin production by B lymphocytes from normal humans. Cell Immunol (May), 44(2): 242-251.
- Rao KM, Schwartz SA, Good RA. (1979) Age-dependent effects of zinc on the transformation response of human lymphocytes to mitogens. Cell Immunol (Feb), 42(2): 270-278.
- O'Reilly RJ, Dupont B, Pahwa S, Grimes E, Smithwick EM, Pahwa R, Schwartz S, Hansen JA, Siegal FP, Sorell M, Svejgaard A, Jersild C, Thomsen M, Platz P, L'Esperance P, Good RA. (1977) Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med (Dec), 297(24): 1311-1318. doi:10.1056/NEJM197712152972403
- Schwartz SA, Choi YS, Shou L, Good RA. (1977) Modulatory effects on immunoglobulin synthesis and secretion by lymphocytes from immunodeficient patients. J Clin Invest (Jun), 59(6): 1176-1187.
- Schwartz SA, Shou L, Good RA, Choi YS. (1977) Suppression of immunoglobulin synthesis and secretion by peripheral blood lymphocytes from normal donors. Proc Natl Acad Sci U S A (May), 74(5): 2099-2103.
- Vogel, J.E., Schwartz, S.A., Cederquist, L.L and Good, R.A. (1977) Suppressor cell activity during human pregnancy. IRCS Med. Sci. (Jan), 5: 489.
- O'Reilly RJ, Everson LK, Emödi G, Hansen J, Smithwick EM, Grimes E, Pahwa S, Pahwa R, Schwartz S, Armstrong D, Siegal FP, Gupta S, Dupont B, Good RA. (1976) Effects of exogenous interferon in cytomegalovirus infections complicating bone marrow transplantation. Clinical immunology and immunopathology (Jul), 6(1): 51-61.
- Shou L, Schwartz SA, Good RA. (1976) Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med (May), 143(5): 1100-1110.
- Boumsell, L., Incefy, G.S., Bernard, A., Schwartz, S., Smithwick, E. and Good, R.A. (1975) Thymocyte differentiation in vitro in ataxia-telangiectasia associated with lymphosarcoma. J Pediatrics (Sep), 87(3): 435-438.
- Schwartz SA, Helinski DR. (1971) Purification and characterization of colicin E1. J Biol Chem (Oct), 246(20): 6318-6327.
- Doolittle RF, Schubert D, Schwartz SA. (1967) Amino acid sequence studies on artiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo. Arch Biochem Biophys (Feb), 118(2): 456-467.
- Schwartz SA, Braun W. (1965) Bacteria as an Indicator of Formation of Antibodies by Single Spleen Cells in Agar. Science (Jul), 149(3680): 200-200.
Books and Book Chapters:
- Mahajan SD, You Y, Aalinkeel R, Reynolds JL, Nair, Bindukumar B, Mammen MJ, Ignatowski TA, Cheng, Chong, Schwartz SA. (2016) Biodegradable Nanoparticle-Based Antiretroviral Therapy across the Blood-Brain Barrier.
- Mahajan SD, Aalinkeel R, Reynolds JL, Nair BB, Mammen MJ, Dai L, Prasad PN, Schwartz SA. (2015) Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases. Elsevier.
- Nair, M.P.N., Schwartz, S.A., Kronfol, Z.A., Pottathil, R., Heimer, E.P., and Greden, J.F. (1991) Suppressive effect of alcohol on normal lymphocyte proliferative responses to HIV antigens. In: Psychiatry and Biological Factors. Plenum Publishing Corp., 269-273.
- Schwartz, S.A. and Rao, K.M.K. (1981) Natural control over immune responses. In: Comprehensive Immunology: Immunodermatology. Plenum, New York, 129-140.
- Choi, Y.S. and Schwartz, S.A. (1979) Synthesis and secretion of immunoglobulins. In: Neonatatal Hepatitis and Biliary Atresia. DHEW Publications No. (NIH) 79-1296. U.S. Government Printing Office, Washington, D.C, 105-117.
Abstracts:
- Parikh NU, Aalinkeel R, Reynolds JL, Quaye E, Cwiklinski K, Sykes DE, Mammen MJ, Sharijkova, A, Khmaladze A, Schwartz SA, Mahajan SD. (2017) Methamphetamine (METH) and HIV-tat mediated oxidative stress contributes to Mitochondrial dysfunction in microglia. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, (Apr)
- Parikh NU, Mammen MJ, Cumella JC, Rockoff JB, Schwartz SA. (2017) Impact of Lung Flute Therapy on Asthma: A Pilot Study. Journal of Allergy and Clinical Immunology, (Feb)
- Aalinkeel R, Abou-Jaoude E, Parikh, N, Reynolds JL, Sykes DE, Mammen MJ, Mahajan SD, Schwartz SA. (2016) Galectin-3 in prostate cancer proliferation and metastasis. European Journal of Immunology, (Aug)
- Parikh NU, Mahajan SD, Aalinkeel R, Reynolds JL, Nair BN, Sykes DE, Mammen MJ, Schwartz SA. (2015) Galectin-1 is Neuroprotectice and Reverses Methamphetamine Induced Blood Brain Barrier Breakdown. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, (May)
- Kumar M.N., El Solh AA, Nair M.P.N., Schwartz SA, Lwebuga-Mukasa JS. (1995) Induction of protooncogenes and apoptosis in uninfected lung alveolar epithelial cells by HIV-1 derived peptides. (abstract). Great Lakes Lung Conference, Ontario, Canada., (Jan)
- Kumar, N.M., El Solh AA, Schwartz SA, Lwebuga-Mukasa JS. (1994) HIV-1 TAT and GP120-derived peptides modulate rat lung alveolar epithelial cell protooncogenes, and cytokine gene expression. (Abstract). Great Lakes Lung Conference, Ontario, Canada, (Jan)
Professional Memberships:
- American Association of Immunologists
- American Federation for Clinical Research
- American Pediatric Society
- American Society for Clinical Investigation
- American Society for Microbiology
- Buffalo Academy of Medicine (Past President)
- Buffalo Allergy Society
- Buffalo Collegium of Immunology (Secretary 2004-present)
- Chilean Society for Allergy and Immunology, Honorary Member
- Fellow of the American Academy of Allergy, Asthma and Immunology
- Indian Society for Immunology
- Society for Pediatric Research
Service Activities:
- Search Committee for the Chair, Department of Dermatology; Member (2009–2010)
- Dean‘s Committee to evaluate the Department of Rehabilitation Medicine; Member (2009–2010)
- Professional Steering Committee for the Merger of Kaleida Health and Erie County Medical Center; Member (2008)
- Medical Executive Committee; Member (2007–2016)
- Chiefs of Service Committee; Member (2007–present)
- The Theodore T. Jacobs, MD Institute of Molecular Medicine and Immunlogy, Organizing Committee; Member (1994–1996)
- Medical Scientist Training Program, Steering and Admissions Committee; Member (1993–2008)
- Renal Transplant Committee
- Search Committee for the Chair, Microbiology and Immunology; Member
- Search Committee for the Chair, Department of Pathology and Anatomical Sciences; Member
- Dean's Committee to assess merger between Surgery and Otolaryngology; Chair
- Grants Review Committee; Member
- Community Awareness and Education; Member